LEE STALEY: Open Payments
NPI 1447566021 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 7 payments from 6 companies in 2025. Trend: 2023 $507 · 2024 $20 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $115 |
| Gilead Sciences, Inc. | 1 | $104 |
| Iovance Biotherapeutics, Inc. | 1 | $46 |
| Coherus Oncology, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $24 |
Products named: RYBREVANT, IMFINZI, Trodelvy, Amtagvi, LOQTORZI, XTANDI.
Industry payments across VA — which companies pay providers there.
